ProCE Banner Activity

CE

High-Alert Medications Heparin, Concentrated Electrolytes, and Magnesium: Practical Strategies in Pursuit of Safety

Video

A product of the Institute for Safe Medication Practices (ISMP).

Pharmacy Technicians: 1.25 contact hours (0.125 CEUs)

Pharmacists: 1.25 contact hours (0.125 CEUs)

Released: May 01, 2022

Expiration: January 05, 2024

No longer available for credit.

Share

Provided by

Provided by ProCE, LLC in partnership with the Institute for Safe Medication Practices (ISMP).

ProCE Banner

Partners

Institute for Safe Medication Practices (ISMP)

ProCE Banner

Additional Information

A product of the Institute for Safe Medication Practices (ISMP).

Program Medium

This program has been made available online.

NOTE: If you attended this live CE activity AND received CE credit (i.e. a Pharmacist or Pharmacy Technician CE statement of credit with ACPE UAN 0221-9999-22-002-L05-P/T), you are not allowed to also receive credit for this home-study on-demand web activity.

Activity Description

Although most medications in healthcare today have a wide margin of safety, there remains some which can cause serious harm or death if they are misused. To reduce the risk of error with these “high-alert” medications, special precautions and high leverage strategies should be implemented to avoid serious patient safety events. Numerous organizations have taken steps to identify these medications, but many are still less than confident that they have taken all the necessary precautions against serious patient harm.

Join the ISMP faculty as we focus particular attention on the potential safe use risks with heparin, concentrated electrolytes, and magnesium using the results from ISMP Medication Safety Self Assessment® for High-Alert Medications. Faculty will review specific safety characteristics of each these important drug classes, describe self-assessment findings related to the use of these medications, and discuss the necessary practice strategies for harm prevention when using these high-alert medications.

Learning Objectives

The intended audience includes: Pharmacists, Physicians, Nurses, PAs, CRNAs, Medication Safety Officers, Quality Professionals, Risk Managers, Leaders in Pharmacy and Nursing, Pharmacy and Anesthesia Technicians. Upon completion of this activity, participants will be able to:

  • Discuss the characteristics of high-alert medications and their impact on patient safety.
  • Describe the low scoring assessment items for heparin, concentrated electrolytes, and magnesium from the ISMP Medication Safety Self Assessment® for High-Alert Medications.
  • Cite at least two effective strategies each for heparin, concentrated electrolytes, and magnesium.

Faculty

Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP

Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP

Susan Paparella, MSN, RN, Vice President, ISMP

CE Accreditation

Release Date: January 25, 2022
Expiration Date: January 25, 2024

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-002-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.25 contact hour (0.125 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Michelle Mandrack, MSN, RN, Christina Michalek, BSc Pharm, RPh, FASHP, and Susan Paparella, MSN, RN, do not have any relevant commercial and/or financial relationships to disclose.

The planners and content peer reviewers from ProCE, LLC and ISMP do not have any relevant financial relationships to disclose

Funding

This CE activity is supported by an educational grant from Baxter. 

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.